Re:Norepinephrine-mediated slow vasomotion drives glymphatic...
by boringg on Wednesday January 15, 2025 @10:33AM
(#42712053)
Question -- will pharma companies try and slander downplay this article?
[ Parent
| on HN ]
Re:Norepinephrine-mediated slow vasomotion drives glymphatic...
by ajmurmann on Wednesday January 15, 2025 @10:45AM
(#42712262)
Seems like this is an issue for the company that makes Ambien but an opportunity for everyone else in that industry (and for patients)
Re:Norepinephrine-mediated slow vasomotion drives glymphatic...
by jayd16 on Wednesday January 15, 2025 @11:03AM
(#42712571)
Why do that when they can sell you even more drugs. Need the glymphowhatever to happily walk down a beach? Try Ambien-G.
Re:Norepinephrine-mediated slow vasomotion drives glymphatic...
by AbstractH24 on Wednesday January 15, 2025 @02:41PM
(#42715913)
There really are no medications on the market indicated for long term use to help with sleep.
Often doctors prescribe low dose Seroquel, but that has its own laundry lists of problems.
Re:Norepinephrine-mediated slow vasomotion drives glymphatic...
by Gud on Wednesday January 15, 2025 @04:05PM
(#42716970)
There is, it’s called weed and is dirt cheap. Might not work for everyone. Might also be illegal at your location.
Re:Norepinephrine-mediated slow vasomotion drives glymphatic...
by AbstractH24 on Wednesday January 15, 2025 @07:24PM
(#42719270)
It also has its adverse effects with long term use.
-someone who has spent a few years now fighting between Seroquel and Weed, assuming the other is the worse choice always.
Re:Norepinephrine-mediated slow vasomotion drives glymphatic...
by Jimmc414 on Wednesday January 15, 2025 @10:39AM
(#42712137)
If you google the article, you see very little mention of Ambien or Zolpidem (edit)
Re:Norepinephrine-mediated slow vasomotion drives glymphatic...
by _Wintermute on Wednesday January 15, 2025 @10:58AM
(#42712485)
It's mentioned in the abstract and 45 times in the article. Most scientists don't use the brand name of a drug.